Literature DB >> 29376008

Tissue plasminogen activator-assisted vitrectomy in the early treatment of acute massive suprachoroidal hemorrhage complicating cataract surgery.

Ping Fei1, Hai-Ying Jin1, Qi Zhang1, Xin Li1, Pei-Quan Zhao1.   

Abstract

Entities:  

Year:  2018        PMID: 29376008      PMCID: PMC5767675          DOI: 10.18240/ijo.2018.01.27

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  5 in total

Review 1.  Tissue plasminogen activator in the treatment of vitreoretinal diseases.

Authors:  M Kamei; M Estafanous; H Lewis
Journal:  Semin Ophthalmol       Date:  2000-03       Impact factor: 1.975

2.  Treatment of suprachoroidal hemorrhage with tissue plasminogen activator.

Authors:  O W Kwon; S J Kang; J B Lee; S C Lee; Y D Yoon; J H Oh
Journal:  Ophthalmologica       Date:  1998       Impact factor: 3.250

3.  Suprachoroidal haemorrhage complicating cataract surgery in the UK: epidemiology, clinical features, management, and outcomes.

Authors:  R Ling; M Cole; C James; S Kamalarajah; B Foot; S Shaw
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

4.  Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage.

Authors:  Nancy Kunjukunju; Christine R Gonzales; William S Rodden
Journal:  Clin Ophthalmol       Date:  2011-02-04

5.  Tissue plasminogen activator-assisted vitrectomy for ruptured eye with suprachoroidal hemorrhage.

Authors:  Koichi Matsumoto; Celso Soiti Matsumoto; Kei Shinoda; Emiko Watanabe; Atsushi Mizota
Journal:  Case Rep Ophthalmol       Date:  2012-08-16
  5 in total
  1 in total

1.  Management of Suprachoroidal Hemorrhage during Cataract Surgery: A Case Report.

Authors:  Seher Koksaldi; Canan Asli Utine; Mustafa Kayabasi
Journal:  Beyoglu Eye J       Date:  2022-02-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.